Arquivamento definitivo - Art. 33 da LPI
#11.1.1
10/01/2019
RPI 2543
Application data
Number
112017027843Type
Filing
Publication
PCT
US2016040158 The application was abandoned: examination was not requested within the 36 months following the 06/29/2016 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 10/01/2019. We update with every new RPI gazette, published weekly.
Applicants
GILEAD SCIENCES, INC.
US
Inventors
J. K. (pessoa física)
US
S. M. (pessoa física)
US
IPC Classification
Priority claims
US
62/187,113 · 06/30/2015
US
62/298,373 · 02/22/2016
US
62/301,429 · 02/29/2016
US
62/317,286 · 04/01/2016
Abstract
A presente invenção se refere a uma forma de dosagem oral sólida a qual compreende alafenamida de tenofovir ou um sal farmaceuticamente aceitável da mesma, e emtricitabina ou um sal farmaceuticamente aceitável da mesma.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
10/01/2019
RPI 2543
#11.1
07/16/2019
RPI 2532
#1.3
09/04/2018
RPI 2487
#1.1
04/03/2018
RPI 2465
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.